Today’s Health Matters

Flickering Light

Rhythmical Photic Stimulation at Alpha Frequencies Produces Antidepressant-Like Effect

Light therapy is increasingly recognized as a potential treatment for neuropsychiatric behaviors and depressive symptoms, with its capacity to influence mood and cognitive functions. Irregular or insufficient light exposure can negatively impact these areas, whereas suitable photic stimulation might offer antidepressant benefits. Traditionally, light therapy has involved prolonged exposure to bright light, but newer approaches using rhythmic photic stimulation with flickering or flashing lights at specific frequencies have shown to be more effective. Such stimulation, particularly at alpha frequencies between 8 to 13 Hz, has been associated with reductions in pain and stress, alongside improvements in behavioral performance. Human depression poses challenges, but models have been instrumental in advancing our understanding of depression's underlying mechanisms. For example, chronic stress through corticosterone exposure display increases in glucocorticoids leading to depression-like behaviors and neurochemical alterations, have all responded favorably to flickering light therapy. Treatments have been effective in reversing these symptoms, providing insights into potential therapeutic strategies. This study focuses on the effects of flickering and flashing light within the alpha frequency range on behaviors such as anxiety, locomotion, social interaction, despair and depression induced by corticosterone. Studies have shown the effectiveness of this photic, flickering light on the above symptoms.

Made with FlippingBook. PDF to flipbook with ease